PD-1 Expression and its Correlation With Prognosis in Clear Cell Renal Cell Carcinoma

被引:7
作者
Kim, Min Hye [1 ,2 ]
Ko, Gyung Hyuk [1 ,2 ,3 ]
Lee, Jeong Hee [1 ,2 ,3 ]
Lee, Jong Sil [1 ,2 ,3 ]
Kim, Dong Chul [1 ,2 ,3 ]
Yang, Jung Wook [1 ,2 ,3 ]
An, Hyo Jung [2 ,3 ,4 ]
Na, Ji Min [1 ]
Song, Dae Hyun [2 ,3 ,4 ]
机构
[1] Gyeongsang Natl Univ Hosp, Dept Pathol, Jinju, South Korea
[2] Gyeongsang Natl Univ, Sch Med, Dept Pathol, 15 Jinjudaero 816 Beon Gil, Jinju 660751, South Korea
[3] Gyeongsang Inst Hlth Sci, Jinju, South Korea
[4] Gyeongsang Natl Univ, Changwon Hosp, Dept Pathol, Chang Won, South Korea
来源
IN VIVO | 2021年 / 35卷 / 03期
关键词
Clear cell renal cell carcinoma; PD-1; survival analysis; prognosis; immunohistochemistry; IMMUNE CHECKPOINTS; CANCER; MOLECULES; PDL1;
D O I
10.21873/invivo.12409
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background/Aim: Programmed death ligand-1 (PD-L1) and programmed death protein 1 (PD-1) expression levels in many tumors and their correlation with prognosis have been actively studied. However, studies on PD-1 expression and its prognostic value in clear cell renal cell carcinoma (ccRCC) are limited and controversial. In this study, we describe the expression of PD-1 and its prognostic significance and association with clinical features in patients with ccRCC. Materials and Methods: We obtained clinicopathological data from 166 patients with ccRCC who were treated at Gyeongsang National University Hospital, Jinju, Korea between January 2000 and December 2009. Tissue microarray blocks were made using representative paraffin blocks of ccRCC specimens. Two pathologists analyzed PD-L1 and PD-1 expression in both tumor and inflammatory cells. Results: PD-1 expression in tumor infiltrating inflammatory cells was significantly correlated with unfavorable disease-free survival (DFS) (p<0.001) and disease-specific survival (DSS) (p=0.002) in the univariate analysis. A statistically significant correlation between PD 1 expression and unfavorable DFS (p=0.025) was observed in the multivariate analysis. Conclusion: PD-1 expression in tumor-infiltrating inflammatory cells serves as an independent prognostic factor for unfavorable DSS in patients with ccRCC.
引用
收藏
页码:1549 / 1553
页数:5
相关论文
共 31 条
[1]   Programmed Death-Ligand 1 Expression and Its Correlation with Lymph Node Metastasis in Papillary Thyroid Carcinoma [J].
An, Hyo Jung ;
Ko, Gyung Hyuck ;
Lee, Jeong-Hee ;
Lee, Jong Sil ;
Kim, Dong Chul ;
Yang, Jung Wook ;
Kim, Min Hye ;
Kim, Jin Pyeong ;
Jung, Eun Jung ;
Song, Dae Hyun .
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2018, 52 (01) :9-13
[2]   ClearCode34: A Prognostic Risk Predictor for Localized Clear Cell Renal Cell Carcinoma [J].
Brooks, Samira A. ;
Brannon, A. Rose ;
Parker, Joel S. ;
Fisher, Jennifer C. ;
Sen, Oishee ;
Kattan, Michael W. ;
Hakimi, A. Ari ;
Hsieh, James J. ;
Choueiri, Toni K. ;
Tamboli, Pheroze ;
Maranchie, Jodi K. ;
Hinds, Peter ;
Miller, C. Ryan ;
Nielsen, Matthew E. ;
Rathmell, W. Kimryn .
EUROPEAN UROLOGY, 2014, 66 (01) :77-84
[3]   Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity [J].
Chen, LP .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (05) :336-347
[4]   Prognostic impact of PD-1 and its ligands in renal cell carcinoma [J].
Erlmeier, Franziska ;
Weichert, Wilko ;
Schrader, Andres Jan ;
Autenrieth, Michael ;
Hartmann, Arndt ;
Steffens, Sandra ;
Ivanyi, Philipp .
MEDICAL ONCOLOGY, 2017, 34 (06)
[5]   Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].
Escudier, B. ;
Porta, C. ;
Schmidinger, M. ;
Rioux-Leclercq, N. ;
Bex, A. ;
Khoo, V. ;
Grunwald, V. ;
Gillessen, S. ;
Horwich, A. .
ANNALS OF ONCOLOGY, 2019, 30 (05) :706-720
[6]   Heterogeneity-of PD-L1 expression in non-small cell lung cancer: Implications for specimen sampling in predicting treatment response [J].
Haragan, Alexander ;
Field, John K. ;
Davies, Michael P. A. ;
Escriu, Carles ;
Gruver, Aaron ;
Gosney, John R. .
LUNG CANCER, 2019, 134 :79-84
[7]   Prognostic Role of PD-L1 Expression in Renal Cell Carcinoma. A Systematic Review and Meta-Analysis [J].
Iacovelli, Roberto ;
Nole, Franco ;
Verri, Elena ;
Renne, Giuseppe ;
Paglino, Chiara ;
Santoni, Matteo ;
Rocca, Maria Cossu ;
Giglione, Palma ;
Aurilio, Gaetano ;
Cullura, Daniela ;
Cascinu, Stefano ;
Porta, Camillo .
TARGETED ONCOLOGY, 2016, 11 (02) :143-148
[8]   Programmed Death-Ligand 1 Immunohistochemistry in Lung Cancer In what state is this art? [J].
Kerr, Keith M. ;
Tsao, Ming-Sound ;
Nicholson, Andrew G. ;
Yatabe, Yasushi ;
Wistuba, Ignacio I. ;
Hirsch, Fred R. .
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (07) :985-989
[9]   Limitations of tissue microarrays compared with whole tissue sections in survival analysis [J].
Khouja, M. Haysam ;
Baekelandt, Mark ;
Sarab, Agkha ;
Nesland, Jahn M. ;
Holm, Ruth .
ONCOLOGY LETTERS, 2010, 1 (05) :827-831
[10]   Prognostic impact of CD8 and programmed death-ligand 1 expression in patients with resectable non-small cell lung cancer [J].
Kim, Seok-Hyun ;
Go, Se-Il ;
Song, Dae Hyun ;
Park, Sung Woo ;
Kim, Hye Ree ;
Jang, Inseok ;
Kim, Jong Duk ;
Lee, Jong Sil ;
Lee, Gyeong-Won .
BRITISH JOURNAL OF CANCER, 2019, 120 (05) :547-554